Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy
Clinical trial NCT05052398 · UNKNOWN
Trial details
- NCT number
- NCT05052398
- Sponsor
- Algenis SpA
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-14
- Primary completion
- 2024-07-11
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.